<DOC>
	<DOC>NCT01322256</DOC>
	<brief_summary>The investigators' primary objective is to assess the predictive power of PET/CT scanning in the evolution of infectious osteoarthritis of the diabetic diabetic after antibiotic therapy prescribed by national and international recommendations.</brief_summary>
	<brief_title>PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>The patient must have given his/her informed and signed consent The patient must be insured or beneficiary of a health insurance plan Patient has type I or type II diabetes Patient consulting in the department of Metabolic and Endocrine Diseases (Caremeau Hospital) or the department of Nutritional Diseases and Diabetology (Grau de Roi Medical Center) at the NÃ®mes University Hospital Patient has infected osteoarthritis of the foot according to the International Working Group on the Diabetic Foot with a probability &gt; 50% (score &gt;= 2). The patient is participating in another study The patient is in an exclusion period determined by a previous study The patient is under judicial protection, under tutorship or curatorship The patient refuses to sign the consent It is impossible to correctly inform the patient The patient is pregnant The patient is breastfeeding Patient has severe sepsis or a stage 4 infection according to the international consensus on the diabetic foot Patient has severe renal insufficiency as defined by glomerular filtration rate &lt; 30ml/min/1.73 m^2, calculated according to the MDRD equation, and is not undergoing dialysis Patient has a contraindication for an MRI pacemaker intracranial clips metallic inclusions severe claustrophobia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>